Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium
Study in Australia on 14 human donors: Astodrimer sodium nasal spray reduced SARS-CoV-2 infectivity by 96.6% and preserved normal mucociliary function.